Abstract
Hyperhomocysteinemia is implicated in retinal neurovascular diseases including arterial occlusive disease, venous occlusive disease and pseudoexfoliation glaucoma. The mechanism for these diseases is not known. Here we used hyperhomocysteinemic mice lacking the gene encoding cystathionine-beta-synthase (cbs −/−) to examine whether ER stress could be a mechanism for the retinal neurovasculopathy reported in these mice. Retinas of cbs+/+ and cbs −/− mice (age: 3–5 wks) were used to investigate the expression of ER stress genes (BiP/GRP78, Perk, Atf6, Atf4, Ire1α, Chop) and the proteins they encode. The levels of poly(ADP-ribose) polymerase (PARP) and cleaved cysteine-aspartic proteases-3 (caspase-3), proteins known to be involved in apoptosis, were also examined. Quantitative reverse transcription polymerase chain reaction and western blotting revealed an increase in BiP/GRP78 and PERK in retinas of cbs −/− mice compared with cbs+/+ mice. There was an elevation of CCAAT-enhancer-binding protein homologous protein (CHOP) in retinal cryosections of cbs −/− mice indicating apoptosis, which was confirmed by increased levels of PARP and cleaved caspase-3. The data suggest that the genes and proteins that are major players in the ER stress pathway, particularly the PERK pathway, are upregulated in retinas of cbs −/− mice. The data support a role for ER stress in the pathophysiology associated with the hyperhomocysteinemia-linked retinal disease.
Keywords: homocysteine, retinal degeneration, retinal neurovasculopathy, apoptosis, BiP/GRP78, cystathionine-β-synthase
Introduction
This study investigated endoplasmic reticulum (ER) stress as a mechanism of homocysteine-linked retinopathy. Homocysteine (Hcy), a key intermediate in metabolism of methionine, is the direct precursor of S-adenosylmethionine (SAM), the most important methyl group donor in the body. Depending upon metabolic demands, Hcy is the substrate for regeneration of methionine (remethylation pathway) or is diverted from the methionine cycle to produce cystathionine and ultimately cysteine (transsulfuration pathway). Normal human fasting plasma levels of Hcy (total Hcy) are 5–15 μmol/l; while hyperhomocysteinemia (HHcy) is classified as: moderate (16–30 μmol/l), intermediate (31–100 μmol/l), severe (>100 μmol/l) [1]. HHcy is an independent risk factor in cardiovascular diseases (stroke, venous thrombosis, peripheral arterial occlusive disease [1–4]) and neurodegenerative diseases (Alzheimer’s and Parkinson’s Diseases) [5,6]. Given that the retina is a neurovascular tissue, it is not surprising that many clinical studies have investigated levels of Hcy in retinopathies [7,8]. HHcy is a risk factor in retinal venous and arterial occlusions [9] including central retinal vein occlusion [10–14]. It has been linked to pseudoexfoliation glaucoma [15–19], macular degeneration [20–22] and diabetic retinopathy [23–25].
HHcy is caused by genetic deficiencies in enzymes responsible for transsulfuration or remethylation of Hcy or by nutritional deficiencies in vitamins serving as cofactors for these enzymes (folate/B12 /B6). The most frequent genetic deficiencies are associated with the enzymes cystathionine beta synthase (CBS) and methylene tetrahydrofolate reductase (MTHFR). There are more than 150 disease-associated CBS mutations, making this the most common genetic cause of severely elevated Hcy [26,27]. The I278T mutation accounts for 25% of all homocystinuric alleles, and is a common cause of homocystinuria (severe HHcy), a genetically inherited, autosomal recessive inborn error of metabolism (1:200,000 live U.S. births) [28]. The cornerstone clinical features of these patients are mental retardation, ectopia lentis, visual deficits and skeletal abnormalities; premature death is typically due to thromboembolic events [29].
Our lab and others have performed in vitro and in vivo studies to elucidate mechanisms of HHcy-linked retinal disease. A clinically relevant experimental system is the mouse deficient or lacking the gene encoding CBS allowing studies of the effects of mild to severe endogenous elevation of Hcy [30]. In previous studies, we examined consequences on retina structure and function using either cbs−/− mice, which have a 30–40 fold increase in plasma Hcy and a shortened life-span of 3–5 weeks; or cbs+/− mice, which have a much milder HHcy with ~4–7 fold increase in plasma Hcy (and a 2-fold increase in retinal Hcy) and a normal lifespan. Our work has shown that both cbs−/− and cbs+/− mice have retinal neuronal involvement and disruption of the retinal vasculature [31–36].
To understand mechanisms for HHcy-induced retinal neuronal death we previously investigated the role of excitotoxicity and oxidative stress using perforated patch clamp analysis and fluorescent detection of intracellular Ca2+ in primary mouse retinal ganglion cells and found that Hcy-induced cell death, which was blocked partially by MK-801, an N-methyl-D-aspartate receptor (NMDA) receptor antagonist [36]. Hcy increased intracellular Ca2+ 7-fold. Additionally exposure of ganglion cells to 50 μM Hcy increased levels of superoxide, nitric oxide and peroxynitrite levels by 40%, 90% and 85%, respectively. We also investigated retinal vasculature in mice with HHcy and observed a marked vasculopathy developing very early in cbs−/− mice associated with increased levels of vascular endothelial growth factor (VEGF) [33]. Interestingly, VEGF has been linked to ER stress in various systems including retina [37–39], prompting this investigation of well-known ER stress markers. We were interested in determining whether ER stress plays a role in Hcy-induced retinal neurovascular pathology observed in cbs−/− mice.
Materials and Methods
Animals
The generation of mice deficient in cbs has been reported [30]. Breeding pairs of cbs+/− mice (B6.129P2-Cbstm1Unc/J; Jackson Laboratories, Bar Harbor, ME) were used to establish our mouse colony. Genotyping, husbandry and housing conditions for the mice have been described [33]. Wildtype (cbs+/+, n = 17) and homozygous mutant (cbs−/−, n = 18) mice were used in this study at ~3 weeks. Mean body weight for cbs+/+ mice (6.84 ± 0.2 g) was significantly greater than age-matched cbs−/− mice (4.53 ± 0.2 g). Experiments adhered to the Association for Research in Vision and Ophthalmology Statement for the Use of Animals in Ophthalmic and Vision Research and followed our animal use protocol approved by the Institutional Animal Care and Use Committee of Georgia Regents University.
Analysis of VEGF levels in retinas of severely hyperhomocysteinemic mice
Elevation of VEGF has been linked to increased ER stress in various tissues, this observation, along with other evidence suggesting ER stress as a mechanism of HHcy-induced pathology, prompted the current experiments. We performed immunohistochemical studies in cryosections using mouse monoclonal anti-VEGF (IgM) (1:250, Abcam Corp., Cambridge, MA) and detected the protein using Alexafluor 488 (donkey anti-mouse antibody, Invitrogen, Eugene, OR). The Metamorph analysis system was used to quantify immunofluorescence levels.
Real time quantitative RT-PCR (RT-qPCR) analysis of genes in the ER stress pathways
Expression levels of mRNA transcripts specific for several key genes involved in ER stress pathways (BiP/GRP78, Perk, Atf6, Ire1α, Atf4, Chop) were examined in neural retinas isolated from cbs+/+ and cbs−/− mice per our method [40]. Total RNA was isolated using TRIzol™ Reagent (Invitrogen, Carlsbad, CA) and quantified. 2 μg of RNA was reverse transcribed using iScript™ Synthesis kit (Bio-Rad Laboratories, Hercules, CA). cDNAs were amplified for 45 cycles using Absolute QPCR SYBR Green Fluorescein (ABgene, Surrey, UK) and gene specific primers (Table 1) using the the BioRad icycler (Hercules, CA). Expression levels were calculated by comparison of Ct values (delta-delta Ct). PCR was performed (40 cycles: 95°C for 30 s; 60°C for 30 s; 72°C for 30 s); melt curve analysis confirmed end product purity. Resulting CT values were normalized to 18s and analyzed using the comparative CT method to obtain fold-changes in gene expression.
Table 1.
Sequences of primers used for qRT-PCR
| Gene | NCBI Accession No. | Primer Sequence | Predicted band size |
|---|---|---|---|
| BiP | NM_022310 | FORWARD: 5′-ACTTGGGGACCACCTATTCCT-3′ | 134 |
| REVERSE: 5′-ATCGCCAATCAGACGCTCC-3′ | |||
| Perk | NM_010121 | FORWARD: 5′-AGTCCCTGCTCGAATCTTCCT-3′ | 125 |
| REVERSE: 5′-TCCCAAGGCAGAACAGATATACC-3′ | |||
| Atf4 | NM_009716 | FORWARD: 5′-TCCTGAACAGCGAAGTGTTG-3′ | 129 |
| REVERSE: 5′-ACCCATGAGGTTTCAAGTGC-3′ | |||
| Ire1α | NM_023913 | FORWARD: 5′-ACACCGACCACCGTATCTCA-3′ | 110 |
| REVERSE: 5′-CTCAGGATAATGGTAGCCATGTC-3′ | |||
| Atf6 | NM_001107196 | FORWARD: 5′-TGCCTTGGGAGTCAGACCTAT-3′ | 141 |
| REVERSE: 5′-GCTGAGTTGAAGAACACGAGTC-3′ | |||
| CHOP | NM_007837 | FORWARD: 5′-CTGGAAGCCTGGTATGAGGAT-3′ | 121 |
| REVERSE: 5′-CAGGGTCAAGAGTAGTGAAGGT-3′ | |||
| 18S | NR_003278 | FORWARD: 5′-AGTGCGGGTCATAAGCTTGC-3′ | 90 |
| REVERSE: 5′-GGGCCTCACTAAACCATCCA-3′ |
Immunoblotting to detect levels of major ER stress proteins
Proteins were extracted from neural retinas isolated from cbs+/+ and cbs−/− mice to detect BiP/GRP78 (immunoglobulin heavy chain-binding protein, a 78 kD glucose regulated protein) (BD Bioscience, San Jose, CA), ATF6 (activating transcription factor-6), CHOP (C/EBP homologous protein) (Santa Cruz Corp., Santa Cruz, CA), PERK (RNA-dependent protein kinase (PKR)-like ER kinase), p-PERK (phosphorylated PERK), cleaved caspase-3 (cysteine-aspartic proteases-3), PARP (poly(ADP-ribose) polymerase) (Cell Signaling, Danvers, MA) per our published method [33]. Protein samples were subjected to SDS-PAGE and transferred to nitrocellulose membranes, which were incubated with the above antibodies at 4°C overnight, followed by a horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG (1:5000) or goat anti-rabbit IgG antibody (1:3000). Nitrocellulose membranes, to which the proteins had been transferred, were incubated with primary antibodies at a concentration ranging from 1:100 to 1:500. They were incubated with HRP-conjugated goat anti-rabbit (Santa Cruz Corp., 1:3000) or goat anti-mouse IgG antibody (Sigma-Aldrich, St. Louis, MO, 1:3000). Proteins were visualized using the SuperSignal West Pico Chemiluminescent Substrate detection system (Pierce Biotechnology, Rockford, IL). Membranes were reprobed with mouse monoclonal anti-β-actin antibody (1:5000) as a loading control. Protein levels were quantified as described [33].
Immunofluorescent assessment of ER stress proteins in retinal cryosections
The ER stress protein BiP/GRP78 as well as CHOP and cleaved caspase-3 were detected using immunofluorescence in cryosections prepared from cbs+/+ and cbs−/− mice per our method [33]. Cryosections were fixed with 4% paraformaldehyde, incubated with PowerBlock followed by incubation with primary antibody for either 3 h at 37°C or overnight at 4°C. Sections were incubated with secondary antibody and coverslipped with Fluoroshield with DAPI (Sigma-Aldrich) to label nuclei. They were visualized by immunofluorescence using an Axioplan-2 fluorescent microscope (Carl Zeiss, Göttingen, Germany) equipped with a high resolution microscope (HRM) camera. Images were captured and processed using Zeiss Axiovision digital image processing software (version 4.7). The Metamorph analysis system was used to quantify immunofluorescence levels. Following our published method [41], neurons of the ganglion cell layer were labeled with NeuN (Neuronal nuclei, red fluorescence) and Brn-3a (green fluorescence) and were counted to determine the number of neurons in this layer in retinas of cbs+/+ and cbs−/− mice. Images were captured from the central, mid-peripheral and peripheral retina on both sides of the optic nerve (6 images from each retinal section), we examined 3 sections per slide and 3 slides per retina. Three mice per group were used in this analysis.
Statistical analysis
qPCR and densitometric scans for western blotting of BiP/GRP78, ATF6, ATF4, IRE1α, PERK, pPERK, CHOP, cleaved caspase-3, cleaved PARP as well as metamorphic quantification of immunofluorescent detection of BiP/GRP78, CHOP, VEGF, cleaved caspase-3 were analyzed using the GraphPad Prism software (La Jolla, CA). Tests used included unpaired t-test, F test for unequal variance, paired t-test and Student’s test. A p value <0.05 was considered significant.
Results
Confirmation that VEGF levels increase in retinas of cbs−/− mice
Increased VEGF levels are linked to increased ER stress. In the current study, we confirmed our previous findings that VEGF levels are increased in retinas of cbs−/− mice [33]. Immunofluorescent detection of VEGF in retinal cryosections revealed marked increase in VEGF in retinas of cbs−/− mice compared with cbs+/+ mice (Fig. 1A). In studies in which the primary antibody was omitted (negative control) or when IgM was used in place of the primary antibody (isotype control) there was no signal detected (data not shown). Metamorph analysis of the color intensity of VEGF labeled cryosections revealed a marked increase in levels in the cbs−/− retinas compared to wildtype retinas Fig. 1B. The data reaffirm our earlier findings [33] that VEGF levels increase in retinas under conditions of severe hyperhomocysteinemia and set the stage for analysis of ER stress in this model.
Fig. 1. Detection of VEGF in in retinas of cbs+/+ and cbs−/− mice.

Retinal cryosections from cbs+/+ and cbs−/− mice were subjected to immunofluorescent detection of VEGF (green fluorescence), a marker of angiogenesis. (B) Quantification of the data obtained from metamorphic analysis of color intensity of VEGF (**p<0.01, n=6). (Calibration bar: 50μm) Abbreviations: GCL = ganglion cell layer, INL = inner nuclear layer, ONL = outer nuclear layer.
Analysis of ER stress genes and proteins in retinas of cbs−/− mice
There have been a number of studies implicating ER stress as a mechanism mediating Hcy-induced atherosclerosis [reviewed in 42]. In retina, there have been many studies implicating ER stress in retinal degenerations [reviewed in 43], however few linking Hcy and ER stress in retinal disease. There was a report that excess Hcy increased VEGF via ER stress in vitro and increased transcription of ATF4 [44], but no studies that examine ER stress in retinas with endogenously elevated Hcy. We explored the in vivo role of Hcy in modulating retinal expression of major ER stress genes including BiP/GRP78 and its downstream effector genes (Perk, Atf6, Ire1α), by analyzing their expression in neural retina of cbs−/− mice compared to wildtype mice. qRT-PCR revealed a significant increase in the expression of BiP/GRP78 and Perk (Fig. 2) in the cbs−/− mouse retina compared with wildtype mice. Interestingly, we observed a trend toward increased levels of ATF6 and ATF4, although the data did not reach statistical difference.
Fig. 2. Analysis of genes encoding the ER stress effector proteins in the neural retina of cbs+/+ and cbs−/− mice.

mRNA of the neural retina was isolated from cbs+/+ and cbs−/− at age ~3–5 weeks old. Real time qRT-PCR was performed to analyze the expression of BiP/GRP78, ATF6, ATF4, IRE1α, PERK, p-PERK and CHOP/GADD34. Levels were normalized to 18S. Each experiment was performed in triplicate;*p <0.05
We examined the expression of the proteins encoded by major ER stress genes Fig. 3A–F). The protein level was expressed as a ratio of band densities of the protein of interest compared to the level of the loading control (β-actin). The analysis of proteins of cbs−/− mice revealed a significant increase in the level of BiP/GRP 78 compared with wildtype (mean ± SEM: 1.386 ± 0.002 (cbs−/−) v. 1.308 ± 0.029 (cbs+/+)) (Fig. 3A). There was a significant increase also in the level of PERK in the cbs−/− mice compared with cbs+/+ mice (mean ± SEM: 1.336 ± 0.0535 (cbs−/−) v. 1.107 ± 0.061 (cbs+/+)) (Fig. 3D). Taken collectively, there appears to be an increase in the major regulator of ER stress as well as involvement of the PERK pathway for ER stress in retinas of HHcy mice.
Fig. 3. Analysis of major ER stress proteins in the neural retina of cbs+/+ and cbs−/− mice.

Proteins from neural retinas of cbs+/+ and cbs−/− mice were isolated and subjected to immunoblotting to detect major proteins implicated in the ER stress response: (A) BiP, (B) ATF6, (C) IRE1α, (D) PERK, (E)p-PERK, (F) CHOP. Band densities were normalized to β-actin and densitometric analysis of the bands are provided next to each blot. (*p<0.05)
Cellular localization of BiP/GRP78 and CHOP: evidence of apoptosis in retinas of cbs−/− mice
We next asked in which retinal cell layers was the increased BiP/GRP78 protein present in cbs−/− mice. There was a marked increase in the level of BiP/GRP78 in the retinas of cbs−/− compared with cbs+/+ mice (Fig. 4A), which was quantified and found to be significant (Fig. 4B). The inner retinal layers, especially the ganglion cell layer, appeared to have greater levels of BiP/GRP78 than did the outer retinal cells. It is well known that if ER stress cannot be suppressed through the cellular machinery for correcting misfolded proteins, then apoptosis will be triggered so that the cell will die allowing the remaining tissue to survive [43,45]. In the ER, apoptosis is signaled through several mechanisms including a PERK-dependent pathway that can cause induction of CHOP. Given that PERK levels were increased in retinas of cbs−/− compared with cbs+/+ mice (Fig. 2 and 3), we examined CHOP in the retinas of these mice. We used immunohistochemical methods to detect CHOP in retinal cryosections (Fig. 4C, D) and found that CHOP levels were markedly increased in the retinas of cbs−/− compared with cbs+/+ mice. As with BiP/GRP78, the inner retina, particularly ganglion cells, and the radially oriented Müller cells appeared to have the most intense expression of CHOP. These data prompted analysis of the numbers of cells in the ganglion cell layer of cbs−/− compared with cbs+/+ mice. To investigate this, we labeled retinal cryosections with the neuronal marker NeuN and the ganglion cell marker Brn-3 using immunohistochemical methods (Fig. 4E). We then counted the number of cells in the ganglion cell layer in the two mouse groups following our published method [41]. The data showed a significant decrease in the number of cells in the ganglion cell layer of the cbs−/− mice compared with age-match wildtype mice (Fig. 4F).
Fig. 4. Immunohistochemical detection of BiP and CHOP in retinas of cbs+/+ and cbs−/− mice and evidence of decreased numbers of retinal ganglion cells in cbs−/− mice.

Retinal cryosections from cbs+/+ and cbs−/− mice were subjected to immunofluorescent detection of (A) BiP (green fluorescence) and (C) CHOP (red fluorescence). The color intensity of BiP (B) and CHOP (D) were quantified using the Metamorph analysis system. (Calibration bar: 50μm, ***p<0.001, n = 6). (E) Neurons of the ganglion cell layer were labeled with neuN (red fluorescence) and Brn-3a (green fluorescence) and were counted to determine the number of neurons in retinas of cbs+/+ and cbs−/− mice; data were depicted graphically (F). (***p<0.001, * p<0.05, n = 6; calibration bar: 50μm,).
CHOP was initially reported as a transcription factor involved in ER stress-induced apoptosis [15]. We explored apoptosis in retinas of cbs−/− mice by examining levels of PARP and cleaved caspase-3. PARP catalyzes the poly(ADP-ribosyl)ation of a variety of nuclear proteins with nicotinamide adenine dinucleotide (NAD) as substrate. It is activated by binding to DNA ends, however when it is cleaved it becomes inactive and can no longer respond to DNA strand breaks [46,47]. The specific cysteine protease that plays a central role in execution of the apoptotic program is caspase-3 [46]. We found a significant increase in the level of cleaved caspase-3 in retinas of the cbs−/− mice (Fig. 5A, B) and a marked increase in the level of cleaved PARP (Fig. 5C,D). In retinal cryosections, there were significantly more cleaved caspase-3 positive cells in retinal cryosections (Fig. 5E,F) of cbs−/− mice compared to cbs+/+ mice. Interestingly, some of the cleaved caspase-3 cells co-localized with isolectin-B4, a marker for blood vessels.
Fig. 5. Evaluation of cleaved caspase-3 and PARP in retinas of cbs+/+ and cbs−/− mice.

Proteins from neural retinas of cbs+/+ and cbs−/− mice were isolated and subjected to immunoblotting to evaluate the levels of apoptotic markers cleaved caspase-3 (A, B) and cleaved PARP (C,D). Band densities were normalized to β-actin and densitometric analysis of the bands are provided next to each blot. (E) Panel of retinal cryosections from cbs+/+ and cbs−/− mice subjected to immunofluorescence methods to detect cleaved caspase-3 and retinal blood vessels in retinal cryosections (blue = DAPI to label nuclei, green = detection of cleaved caspase-3, red = detection of retinal vessels using isolectin-B4). (F) The number of cleaved caspase -3 positive cells were counted in cryosections (*p <0.05; calibration bar: 50μm).
Discussion
The present study examined ER stress in the retinal neurovasculopathy observed in mice with severely elevated levels of Hcy. HHcy is relevant to human retinal neurovasculopathies, including retinal vein occlusion, retinal artery occlusion and psuedoexfoliation glaucoma [7–19]. Clinical studies are often inconclusive with respect to mechanisms underlying disease. In vitro studies, in which neuronal or vascular cell types are incubated with varying concentrations and formulations of Hcy, provide some clues about pathological mechanisms, although endogenously occurring models are likely to provide insights that will be more relevant to human pathophysiology. For these reasons, we have been investigating mechanisms by which moderate to severe endogenous elevation of Hcy may alter the neurons or vessels of the retina and have used mouse models that have genetic defects in the Hcy metabolic pathway.
The cbs−/− mouse used in this study is an example of very severely elevated plasma Hcy (and ~7-fold elevation of retinal Hcy). The marked neuronal death and vascular pathology observed in the retina are evident within the first three weeks of life [31,33,35]. The model has provided an excellent opportunity to investigate mechanisms of Hcy-induced retinal neurovasculopathy over a very short time frame, in this case 3–5 weeks. The cbs+/− mouse, which is less severe HHcy, has also proven useful in mechanistic studies of Hcy-induced retinal disease [31,32,34,36,48].
ER stress is a fundamental cellular process. Typically, proteins are translocated into the ER lumen in an unfolded state and require protein chaperones/catalysts of protein folding to attain their final correct conformation. A sensitive system exists to prevent misfolded proteins from progressing through the secretory pathway; it directs them toward a degradative pathway [49–51]. The processes that prevent accumulation of unfolded proteins in the ER lumen are regulated by an intracellular signaling pathway known as the unfolded protein response (UPR), which facilitates cellular adaptation to alterations in protein-folding in the ER lumen by expanding the capacity for protein folding. This is accomplished by molecular chaperone proteins (BiP/GRP78). When unfolded proteins accumulate in the ER, BiP/GRP78 releases transmembrane ER proteins (e.g. PERK, IRE1, ATF6) inducing the UPR. In the current study, we explored ER stress genes and proteins in retinas of cbs−/− mice compared to wildtype mice. Our data showed an increase in several ER stress genes/proteins including BiP/GRP78 and PERK. They suggest that ER stress, like oxidative stress and excitotoxicity, is a key mechanism in the retinal neurovasculopathy associated with excess levels of Hcy.
Earlier comprehensive investigation of the retinal vasculature in these mice revealed ischemia, neovascularization and a diminished blood-retinal barrier [33]. Accompanying these pathological changes were increased levels of VEGF mRNA and protein. Increased VEGF levels, which we observed also in this study, are associated with increased ER stress [37,38]. Abcouwer and colleagues performed in vitro studies investigating the role of HHcy in upregulating VEGF in ARPE-19 cells via an ER stress-mediated pathway [44], but there have been no investigations of HHcy and ER stress in retina in vivo. The present studies fill that void.
In the current work, we demonstrate upregulation of ER stress genes in the retinas of the cbs−/− mouse, particularly BiP/GRP78 and PERK, providing strong evidence that ER stress is induced in this model. BiP/GRP78 is associated with PERK, which is the major protein responsible for attenuation of mRNA translation during ER stress. It prevents influx of newly synthesized proteins into ER, which is not able to manage the additional protein folding load [52]. However, if the unfolded protein response does not alleviate this stress, the pathways for apoptosis are activated, which includes PERK. Our data show that PERK is elevated at the gene and protein level in the cbs−/− retina. Elevation of PERK can in turn upregulate the pro-apoptotic transcriptional factor CHOP. While we did not observe a significant increase of CHOP at the gene or protein level in retinas of cbs−/− mice by qRT-PCR and western blotting, we did we detect an increase in CHOP in specific retinal layers (nerve fiber layer, ganglion cell inner nuclear layer) using immunohistochemical methods. Since CHOP is implicated in apoptosis, we explored markers of apoptosis and found that both PARP and caspase-3 were elevated significantly in the retinas of severely HHcy mice. Interestingly, we found that the caspase-3 positive cells also labeled positively for the vessel marker isolectin-B4, which may be relevant to the vasculopathy observed in the cbs−/− mice.
In summary, the present study presents the first systematic investigation of the role of ER stress in HHcy-induced retinal disease. The evidence suggests that the genes and proteins that are major players in the ER stress pathway are upregulated in retinas of mice with severe HHcy due to a defect in the transsulfuration pathway. The data support a role for ER stress in the pathophysiology associated with HHcy-linked retinal disease. Whether the ER stress observed is causative of the neurovasculopathy or a response to it, is not known. Future studies will explore this and will also investigate whether ER stress plays a role in HHcy-linked retinopathies that are due to deficiencies of other enzymes in the Hcy metabolic pathway, particularly the remethylation pathway. Additional experiments are underway to examine whether inhibiting ER stress has any positive effect on the neurovasculopathy observed in the HHcy-induced retinopathy.
Acknowledgments
The authors thank Yonju Ha, PhD for designing the primers used for analysis of ER stress genes and Mrs. Penny Roon for excellent assistance with histological preparations of mouse retina.
Grant support: NIH grant R01 EY012830 and the James and Jean Culver Vision Discovery Institute
Abbreviations
- ER
endoplasmic reticulum
- Hcy
homocysteine
- HHcy
hyperhomocysteinemia
- SAM
S-adenosylmethionine
- CBS
cystathionine beta synthase
- MTHFR
methylene tetrahydrofolate reductase
- NMDA
N-methyl-D-aspartate receptor
- VEGF
vascular endothelial growth factor
- UPR
unfolded protein response (UPR)
- BiP/GRP78
immunoglobulin heavy chain-binding protein
- CHOP
CCAAT-enhancer-binding protein homologous protein
- PERK
PKR-like endoplasmic reticulum kinase
- IRE1
inositol-requiring enzyme 1
- ATF6
activating transcription factor 6
- ATF4
activating transcription factor 4
- qRT-PCR
quantitative reverse transcription polymerase chain reaction
- HRP
horseradish peroxidase
Literature cited
- 1.Perła-Kaján J, Twardowski T, Jakubowski H. Mechanisms of homocysteine toxicity in humans. Amino Acids. 2007;32:561–572. doi: 10.1007/s00726-006-0432-9. [DOI] [PubMed] [Google Scholar]
- 2.Maron BA, Loscalzo J. The treatment of hyperhomocysteinemia. Annu Rev Med. 2009;60:39–54. doi: 10.1146/annurev.med.60.041807.123308. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. Br Med J. 2002;325:1202. doi: 10.1136/bmj.325.7374.1202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA. 2002;288:2015–2022. doi: 10.1001/jama.288.16.2015. [DOI] [PubMed] [Google Scholar]
- 5.Agnati LF, Genedani S, Rasio G, Galantucci M, Saltini S, Filaferro M, Franco R, Mora F, Ferre S, Fuxe K. Studies on homocysteine plasma levels in Alzheimer’s patients. Relevance for neurodegeneration. J Neural Transm. 2005;112:163–169. doi: 10.1007/s00702-004-0154-7. [DOI] [PubMed] [Google Scholar]
- 6.Hogervorst E, Ribeiro HM, Molyneux A, Budge M, Smith AD. Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. Arch Neurol. 2002;59:787–793. doi: 10.1001/archneur.59.5.787. [DOI] [PubMed] [Google Scholar]
- 7.Semba RD. Nutrition and Health: Handbook of Nutrition and Ophthalmology. Humana Press Inc; Totowa, NJ: 2007. Retinal Vascular Disease; pp. 257–280. [Google Scholar]
- 8.Wright AD, Martin N, Dodson PM. Homocysteine, folates, and the eye. Eye (Lond) 2008;22:989–993. doi: 10.1038/sj.eye.6703061. [DOI] [PubMed] [Google Scholar]
- 9.Cahill MT, Stinnett SS, Fekrat S. Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease. Am J Ophthalmol. 2003;136:1136–1150. doi: 10.1016/s0002-9394(03)00571-3. [DOI] [PubMed] [Google Scholar]
- 10.Jaksic V, Markovic V, Milenkovic S, Stefanovic I, Jakovic N, Knezevic M. MTHFR C677T homozygous mutation in a patient with pigmentary glaucoma and central retinal vein occlusion. Ophthalmic Res. 2010;43:193–196. doi: 10.1159/000272023. [DOI] [PubMed] [Google Scholar]
- 11.Gao W, Wang YS, Zhang P, Wang HY. Hyperhomocysteinemia and low plasma folate as risk factors for central retinal vein occlusion: a case-control study in a Chinese population. Graefes Arch Clin Exp Ophthalmol. 2006;244:1246–1249. doi: 10.1007/s00417-005-0191-4. [DOI] [PubMed] [Google Scholar]
- 12.Gumus K, Kadayifcilar S, Eldem B, Saracbasi O, Ozcebe O, Dundar S, Kirazli S. Is elevated level of soluble endothelial protein C receptor a new risk factor for retinal vein occlusion? Clin Experiment Ophthalmol. 2006;34:305–311. doi: 10.1111/j.1442-9071.2006.01212.x. [DOI] [PubMed] [Google Scholar]
- 13.Abu El-Asrar AM, Al-Obeidan SA, Abdel Gader AG. Retinal periphlebitis resembling frosted branch angiitis with nonperfused central retinal vein occlusion. Eur J Ophthalmol. 2003;13:807–812. doi: 10.1177/1120672103013009-1015. [DOI] [PubMed] [Google Scholar]
- 14.Lahey JM, Kearney JJ, Tunc M. Hypercoagulable states and central retinal vein occlusion. Curr Opin Pulm Med. 2003;9:385–392. doi: 10.1097/00063198-200309000-00008. [DOI] [PubMed] [Google Scholar]
- 15.Tranchina L, Centofanti M, Oddone F, Tanga L, Roberti G, Liberatoscioli L, Cortese C, Manni G. Levels of plasma homocysteine in pseudoexfoliation glaucoma. Graefes Arch Clin Exp Ophthalmol. 2011;249:443–448. doi: 10.1007/s00417-010-1487-6. [DOI] [PubMed] [Google Scholar]
- 16.Turgut B, Kaya M, Arslan S, Demir T, Güler M, Kaya MK. Levels of circulating homocysteine, vitamin B6, vitamin B12, and folate in different types of open-angle glaucoma. Clin Interv Aging. 2010;5:133–139. doi: 10.2147/cia.s9918. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Roedl JB, Bleich S, Reulbach U, Rejdak R, Kornhuber J, Kruse FE, Schlötzer-Schrehardt U, Jünemann AG. Homocysteine in tear fluid of patients with pseudoexfoliation glaucoma. J Glaucoma. 2007;16:234–239. doi: 10.1097/IJG.0b013e31802d6942. [DOI] [PubMed] [Google Scholar]
- 18.Roedl JB, Bleich S, Reulbach U, Rejdak R, Naumann GO, Kruse FE, Schlötzer-Schrehardt U, Kornhuber J, Jünemann AG. Vitamin deficiency and hyperhomocysteinemia in pseudoexfoliation glaucoma. J Neural Transm. 2007;114:571–575. doi: 10.1007/s00702-006-0598-z. [DOI] [PubMed] [Google Scholar]
- 19.Schlötzer-Schrehardt U. Oxidative stress and pseudoexfoliation glaucoma. Klin Monbl Augenheilkd. 2010;227:108–113. doi: 10.1055/s-0028-1109977. [DOI] [PubMed] [Google Scholar]
- 20.Javadzadeh A, Ghorbanihaghjo A, Bahreini E, Rashtchizadeh N, Argani H, Alizadeh S. Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein. Retina. 2012;32:658–666. doi: 10.1097/IAE.0b013e31822529b1. [DOI] [PubMed] [Google Scholar]
- 21.Carrillo-Carrasco N, Venditti CP. Combined methylmalonic acidemia and homocystinuria, cblC type. II. Complications, pathophysiology, and outcomes. J Inherit Metab Dis. 2012;35:103–114. doi: 10.1007/s10545-011-9365-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Javadzadeh A, Ghorbanihaghjo A, Bahreini E, Rashtchizadeh N, Argani H, Alizadeh S. Plasma oxidized LDL and thiol-containing molecules in patients with exudative age-related macular degeneration. Mol Vis. 2010;16:2578–2584. [PMC free article] [PubMed] [Google Scholar]
- 23.Lim CP, Loo AV, Khaw KW, Sthaneshwar P, Khang TF, Hassan M, Subrayan V. Plasma, aqueous and vitreous homocysteine levels in proliferative diabetic retinopathy. Br J Ophthalmol. 2012;96:704–707. doi: 10.1136/bjophthalmol-2011-301044. [DOI] [PubMed] [Google Scholar]
- 24.Cho HC. The Relationship among Homocysteine, Bilirubin, and Diabetic Retinopathy. Diabetes Metab J. 2011;35:595–601. doi: 10.4093/dmj.2011.35.6.595. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Satyanarayana A, Balakrishna N, Pitla S, Reddy PY, Mudili S, Lopamudra P, Suryanarayana P, Viswanath K, Ayyagari R, Reddy GB. Status of B-vitamins and homocysteine in diabetic retinopathy: association with vitamin-B12 deficiency and hyperhomocysteinemia. PLoS One. 2011;6:e26747. doi: 10.1371/journal.pone.0026747. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Garovic-Kocic V, Rosenblatt DS. Methionine auxotrophy in inborn errors of cobalamin metabolism. Clin Invest Med. 1995;15:395–400. [PubMed] [Google Scholar]
- 27.Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med. 1998;338:1042–1050. doi: 10.1056/NEJM199804093381507. [DOI] [PubMed] [Google Scholar]
- 28.Maron BA, Loscalzo J. Should hyperhomocysteinemia be treated in patients with atherosclerotic disease? Curr Atheroscler Rep. 2007;9:375–383. doi: 10.1007/s11883-007-0048-x. [DOI] [PubMed] [Google Scholar]
- 29.McCully KS. Vascular pathology of homocysteine-emia: implications for the pathogenesis of arteriosclerosis. Am J Pathol. 1969;56:111–128. [PMC free article] [PubMed] [Google Scholar]
- 30.Watanabe M, Osada J, Aratani Y, Kluckman K, Reddick R, Malinow MR. Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocysteinemia. Proc Natl Acad Sci USA. 1995;92:1585–1589. doi: 10.1073/pnas.92.5.1585. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Ganapathy PS, Moister B, Roon P, Mysona B, Duplantier J, Dun Y, Moister TK, Farley MJ, Prasad PD, Liu K, Smith SB. Endogenous Elevation of Homocysteine Induces Retinal Ganglion Cell Death in the Cystathionine-β-synthase Mutant Mouse. Invest Ophthalmol Vis Sci. 2009;50:4460–4470. doi: 10.1167/iovs.09-3402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Ganapathy PS, Roon P, Moister TK, Mysona B, Smith SB. Diabetes accelerates retinal neuronal cell death in a mouse model of endogenous hyperhomocysteinemia. Ophthalmol and Eye Dis. 2009;1:3–11. doi: 10.4137/oed.s2855. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Tawfik A, Al-Shabrawey M, Roon P, Sonne S, Covar JA, Matragoon S, Ganapathy PS, Atherton SS, El-Remessy A, Ganapathy V, Smith SB. Alterations of retinal vasculature in cystathionine-beta-synthase mutant mice, a model of hyperhomocysteinemia. Invest Ophthalmol Vis Sci. 2013;54:939–49. doi: 10.1167/iovs.12-10536. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Tawfik A, Markand S, Al-shabrawey M, Henry J, Reynolds J, Bearden SE, Ganapathy V, Smith SB. Alterations of retinal vasculature in cystathionine-beta-synthase heterozygous mice, a model of mild-moderate hyperhomocysteinemia. Amer J Pathology. doi: 10.1016/j.ajpath.2014.05.018. In Press. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Yu M, Sturgill-Short G, Ganapathy P, Tawfik A, Peachey NS, Smith SB. Age-related changes in visual function in cystathionine-beta-synthase mutant mice, a model of hyperhomocysteinemia. Exp Eye Res. 2012;96:124–131. doi: 10.1016/j.exer.2011.12.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Ganapathy P, White R, Ha Y, Bozard BR, McNeil P, Caldwell RW, Kumar S, Black S, Smith SB. The role of N-Methyl-D-Aspartate receptor activation in homocysteine-induced death of retinal ganglion cells. Invest Ophthalmol Vis Sci. 2011;52:5515–5524. doi: 10.1167/iovs.10-6870. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Pereira ER, Frudd K, Awad W, Hendershot LM. Endoplasmic reticulum (ER) stress and hypoxia response pathways interact to potentiate hypoxia-inducible factor 1 (HIF-1) transcriptional activity on targets like vascular endothelial growth factor (VEGF) J Biol Chem. 2014;289:3352–3364. doi: 10.1074/jbc.M113.507194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Pollreisz A, Afonyushkin T, Oskolkova OV, Gruber F, Bochkov VN, Schmidt-Erfurth U. Retinal pigment epithelium cells produce VEGF in response to oxidized phospholipids through mechanisms involving ATF4 and protein kinase CK2. Exp Eye Res. 2013;116:177–184. doi: 10.1016/j.exer.2013.08.021. [DOI] [PubMed] [Google Scholar]
- 39.Wang X, Wang G, Kunte M, Shinde V, Gorbatyuk M. Modulation of angiogenesis by genetic manipulation of ATF4 in mouse model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2013;54:5995–6002. doi: 10.1167/iovs.13-12117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Ha Y, Shanmugam AK, Markand S, Zorrilla E, Ganapathy V, Smith SB. Sigma receptor 1 modulates ER stress and Bcl2 in murine retina. Cell Tissue Res. 2014;356:15–27. doi: 10.1007/s00441-013-1774-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Ha Y, Saul A, Tawfik A, Zorrilla EP, Ganapathy V, Smith SB. Diabetes accelerates retinal ganglion cell dysfunction in mice lacking sigma receptor 1. Mol Vis. 2012;18:2860–2870. [PMC free article] [PubMed] [Google Scholar]
- 42.Zhou J, Austin RC. Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms. Biofactors. 2009;35:120–129. doi: 10.1002/biof.17. [DOI] [PubMed] [Google Scholar]
- 43.Zhang SX, Sanders E, Fliesler SJ, Wang JJ. Endoplasmic reticulum stress and the unfolded protein responses in retinal degeneration. Exp Eye Res. 2014 doi: 10.1016/j.exer.2014.04.015. (In Press) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Roybal CN, Yang S, Sun CW, Hurtado D, Vander Jagt DL, Townes TM, Abcouwer SF. Homocysteine increases the expression of vascular endothelial growth factor by a mechanism involving endoplasmic reticulum stress and transcription factor ATF4. J Biol Chem. 2004;279:14844–14852. doi: 10.1074/jbc.M312948200. [DOI] [PubMed] [Google Scholar]
- 45.Oyadomari S, Mori M. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ. 2004;11:381–389. doi: 10.1038/sj.cdd.4401373. [DOI] [PubMed] [Google Scholar]
- 46.Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 1995;376:37–43. doi: 10.1038/376037a0. [DOI] [PubMed] [Google Scholar]
- 47.Tewari M, Quan LT, O’Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 1995;81:801–809. doi: 10.1016/0092-8674(95)90541-3. [DOI] [PubMed] [Google Scholar]
- 48.Ganapathy PS, Perry RL, Tawfik A, Smith RM, Perry E, Roon P, Bozard BR, Ha Y, Smith SB. Homocysteine-mediated modulation of mitochondrial dynamics in retinal ganglion cells. Invest Ophthalmol Vis Sci. 2011;52:5551–5558. doi: 10.1167/iovs.11-7256. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Smith SB. In: ER stress and retinal disease Retina. 5. Ryan SJ, Schachat AP, Wilkinson CP, Hinton DR, Sadda S, Wiedemann P, editors. Elsevier; London: 2012. [Google Scholar]
- 50.Malhotra JD, Kaufman RJ. The endoplasmic reticulum and the unfolded protein response. Semin Cell Dev Biol. 2007;18:716–731. doi: 10.1016/j.semcdb.2007.09.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Oshitari T, Hata N, Yamamoto S. Endoplasmic reticulum stress and diabetic retinopathy. Vasc Health Risk Manag. 2008;4:115–122. doi: 10.2147/vhrm.2008.04.01.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Sano R, Reed JC. ER stress-induced cell death mechanisms. Biochim Biophys Acta. 2013;1833:3460–3470. doi: 10.1016/j.bbamcr.2013.06.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
